SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?


To: NeuroInvestment who wrote (958)6/26/2002 7:39:22 PM
From: Miljenko Zuanic  Respond to of 1834
 
Harry,

Do you have in-vitro and in-vivo data for 34060 affinity to different GABA-A receptors? So far NBIX only mentioned 50-100 time more potent (for omega-1) than Sonata, while 20 mg dose do not support this claim???

Thanks,

Miljenko



To: NeuroInvestment who wrote (958)6/26/2002 8:03:49 PM
From: keokalani'nui  Read Replies (1) | Respond to of 1834
 
>>'Land with both feet'...I guess I am going to have to watch myself more carefully, if I have earned that reputation in the past....<<

Not at all. Just (me) being a self-conscious pip-squeak. Thank you for the answer.

Wilder